There has been an increasing demand for the development of cell-labeling nanomaterials that safely label and visualize a specific type of cells for diagnosis and inspection in vivo and in vitro. In order to design such cell-labeling nanomaterials, the properties of efficient visible light luminescence and effective interactions with cells have to be realized using a biocompatible nanomaterial. From this viewpoint, we summarize and overview the current situation on cell-labeling technologies. Among various functional nanomaterials, we focus on hydroxyapatite nanoparticles and their photofunctionalization based on the properly designed inorganic-organic hybrid structure such as hydroxyapatite/ organic europium (III) complex. Also, the immobilization technique of a specific binding molecule to the solid surface is introduced to demonstrate the selective uptake into cancer cells. Moreover, an example of the growth inhibitory drug molecules for cancer cells are described, focusing on the cytostatic inhibition of citric acid and the potential use of hydroxyapatite/citric acid hybrids. Finally, we mention our future perspectives on the theranostic nanoparticles with fluorescence and therapeutic properties that are achieved through the hydroxyapatiteorganic hybrid interfacial interactions.
INTRODUCTION
Pathological diagnosis and noninvasive therapy have been extensively investigated so far by means of a variety of techniques. Among them, nanomaterials that can bind to the surface of cells and fluoresce by light irradiation with a specific wavelength are well-known as cell-labeling nanomaterials and have been widely utilized for various purposes [1] [2] [3] [4] .
Many different types of cell-labeling technologies have been developed for the diagnosis of cancer cells including radioisotopes for single photon emission computed tomography (SPECT), positron emission tomography (PET) [5] , iron-nanoparticles for magnetic resonance imaging (MRI) [6] , and antibody-mediated labeling with optical probes [7] . However, the application of these techniques to early-stage cancer cells is still a grand challenge in this field. In order to overcome various difficulties, one of the keys would be to develop diagnostic techniques using a fluorescence endoscope to detect the epithelial cancer cells.
Other important features that are demanded for the cell-labeling nanomaterials are that they can safely label and visualize the cancer cells for diagnosis and inspection in vivo and in vitro. To realize such celllabeling nanomaterials, nanomaterial itself has to be biocompatible, efficiently fluoresce in the visible light range (400-800 nm) as well as effectively interact with the cells. For the early stage detection of the cancer cells in vivo, the surface layer of the cells is stained to be observed with a fluorescence endoscope. Then, the cells are diagnosed on the basis of autofluorescence which is known as a fluorescence emitted by cell constituents. A previous study reported that clear luminescence peaks were observed at approximately 500 nm and 630 nm when excited at a wavelength of 437 nm [8] . However, the luminescence intensity of autofluorescence is too weak to confirm with our naked eyes, limiting practical use of this phenomenon to various applications. For this reason, many researchers have started from in vitro studies to achieve luminescence that can sufficiently be observed with a fluorescent endoscope, probably leading to the cell diagnosis in vivo afterwards.
Although the detection limit of a confocal laser scanning microscope in z direction is known to be approx. 500 nm [9] , some holographic microscopes can observe almost 30 m in depth from the cellular top surface. Taking advantage of these techniques, the cell-labeling nanomaterials can be utilized for immunoassay to diagnose early stage cancer in the visible light region.
To further develop and optimize nanomaterials with desired cell labeling properties, a possible mechanism on how the nanomaterials are captured by cells is considered in relation to the basic structure of cells.
Endocytosis is known as one of the representative processes in which the nanomaterial is taken into the cell from the outside via the cell membrane [10] . There are two types of endocytosis: phagocytosis and pinocytosis Phagocytosis is a mechanism that cells take up foreign substances (bacteria, viruses, parasites) and abnormal metabolites into the cell (tissue, Regen Med Front. 2020;2(1):e200001. https://doi.org/10.20900/rmf20200001
Regenerative Medicine Frontiers 3 of 27 blood, etc.) and decompose them. Phagocytosis occurs only in a specific type of cells such as phagocytic cells, monocytes, dendritic cells, NK cells and neutrophils. Pathogens, dead cells and cell debris (1 µm or more) are also included. On the other hand, pinocytosis refers to the phenomenon that cells take up nanomaterials as vesicles regardless of their permeability. Internalization of substances with the size less than 300 nm [11] and 50 to 80 nm [12] into cells have been reported. No clear consensus has been obtained so far with respect to the mechanism of nanomaterial uptake into cells. The surface physical properties are regarded as one of the important factors, while the uptake behavior also varies depending on the types of cells. Since proteins and nanomaterials in vivo bind to each other and agglutinate, the cellular uptake mechanism does not depend only on the size of the nanomaterials. Pinocytosis depends on the size, composition and structure of the nanomaterial surface.
In this review, we summarize and overview some aspects and future challenges of the cell-labeling techniques. The cell-labeling techniques have the potential to be improved by the development of cytocompatible photoluminescence probes [13, 14] . For example, lanthanide (Ln) iondoped nanomaterials provide several advantages such as lower cytotoxicity, photostability and sharp luminescence bands over the conventional cell-labeling nanomaterials including organic molecules and semiconductor quantum dots [15, 16] . From this viewpoint, we describe the importance of photofunctionalization of hydroxyapatite, which is realized by designing the inorganic-organic nanohybrid structures. We also highlight the surface immobilization technique of nanomaterials, making it possible to control uptake into cancer cells. Figure 1 shows an outline of the labeling mechanism (endocytosis). On the basis of the interaction between a nanomaterial surface and cell membrane (receptor), endocytosis is classified into two behaviors: passive and active. The former is a weak liquid phase interaction such as hydrogen bonding, a hydrophobic effect and van der Waals force. In such cases, the nanomaterials are easily taken into the cells since surface energy is same as that of cell surfaces. The latter is a strong liquid phase/solid phase interaction such as ionic bonding, metal bonding and covalent bonding, etc. In the case of the strong interaction, the catalytic effect at the interaction point inhibits cellular uptake because of the high surface tension. The nanomaterial taken up by the cell is carried to the lysosome, 
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Labeling Mechanism
Figure 1.
Illustration of the possible cell-labeling mechanism for diagnosis. The site to be taken into the cell is different depending on the particle size as described in the text.
Conventional Nanomaterials
Organic molecules
Organic molecules and inorganic nanoparticles have been used as celllabeling nanomaterials. Depending on the nanomaterial, there are some problems such as fast color degradation which is due to ultraviolet light excitation, damaging the living tissue (influence of active oxygen generated by photochemical reaction, damage of biomolecules due to electron transfer reaction, etc.). A variety of nanomaterials have been synthesized so far; however, there are still no suitable nanomaterials to solve such problems. Some examples of cell-labeling nanomaterials already reported and known problems are shown in Table 1 . For the organic molecules, a fluorescent protein (excitation wavelength: 400 nm) [17] , fluorescent organic small molecule (excitation wavelength: 370 nm) [18] , temperature responsive polymers (excitation wavelength: 456 nm) [19] and pH responsive dye (excitation wavelength: 532 nm) [20] such drawbacks are seen with the temperature responsive and pH responsive dyes, some other difficulties including water insolubility and aggregate formation limit their usage in cell-labeling applications. For this kind of applications, it is necessary to synthesize nanomaterials which have sufficient stability in their color and luminescence properties even under continuous/strong light excitation. Table 1 . Conventional cell-labeling nanomaterials of organic molecular state solved in solution and inorganic particle state dispersed in solution, and their problems [13, 14, 16, 17, [19] [20] [21] [22] [23] . 
Luminescent nanomaterial
Inorganic nanoparticles
Among various inorganic nanoparticles, semiconductor quantum dots (excitation wavelength: 260 nm) have been mainly utilized for celllabeling applications [21] because of their strong luminescence and stable color. However, a problem has been also reported in terms of biotoxicity which is induced by compositional Cd, Hg, etc. (biotoxic element) [13, 14, 21] .
These heavy metals are known to affect the cell function and reduce cell viability, possibly leading to undesirable and/or unexpected results in in vivo experiments. In addition, since the quantum dots are usually excited by UV light irradiation, potential damage to the cells is also concerned. To solve this problem, a Ln ion-doped oxide which is excited by the light with longer wavelength has been reported as the cell-labeling nanomaterial [16, 22, 23] , while its luminescent properties and safety to cells are unknown yet ( Table 1) .
In order to overcome these barriers, a Ln ion-doped hydroxyapatite 
APPLICATION OF HYDROXYAPATITE FOR CELL-LABELING
NANOMATERIALS
Hydroxyapatite
Features
The HA (Ca10(PO4)6(OH)2) with a Ca/P ratio of 1.67 is an inorganic component contained in living tissues (bones and teeth), the crystal system is hexagonal, the space group is P63/m, and the unit cell is 0.94 nm × 0.94 nm × 0.68 nm [24] . As a crystal structure, the four columnar Ca (i.e., Ca (I) site) is aligned parallel to the c axis, and the six screw axis Ca (i.e., Ca (II) site) surround the c-axis. Also, hydroxyl groups are present in the part surrounded by the screw Ca. The crystal structure of HA is shown in Figure 2 . The high biocompatibility due to having a composition close to the hard tissues in vivo is an advantage, and applied study as a biomaterial is proceeding. The reported particle size of HA is around 20-300 nm [25, 26] , and it has excellent light resistance. The uptake of the HA nanoparticles with a size of 50-200 nm by the osteoblasts has been investigated, exhibiting the excellent uptake efficiency without cytotoxicity [27] . The Ca ions in the HA can be easily substituted with the other metal ions, and by substituting Ln ions, a luminescence property can be imparted. By using the HA matrix, it is possible to achieve the cell-labeling nanomaterials that are safe for the living body and do not affect the color degradation and luminescence properties due to the light excitation. Furthermore, since it is possible to impart the other functions (e.g., drug delivery carrier) for achieving the multi-functional particles, it is important to design the celllabeling nanomaterials as nanoparticle shapes. lepidochrocite (α-, γ-FeOOH) is exposed on the surface, and exists as an inorganic-organic hybrid by interacting with α-chitin and proteins [28] [29] [30] .
This inorganic-organic hybrid is achieved by the chemical bond of the Fe 2+ ion of α-and γ-FeOOH with the carboxyl group and hydroxyl group in the α-chitin and proteins.
The bone tissue in vivo is also the same. The study on the synthesis of functional nanoparticles has been conducted using biomineralization [31, 32] . The possibility of the development of the novel cell-labeling nanoparticles by mimicking biomineralization is expected.
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Incorporation of Hydroxyapatite Nanoparticles into Cells
The interaction between cytophilic nanoparticles and cells depends on the particle size, surface structure, chemical composition, solubility and aggregation. These are important for circulation in the body, invasiveness to lesions and accumulation, and can be expected to improve the effects of diagnosis and therapy.
The substances diffuse into the cells due to the concentration gradient.
The transport of the substances inside and outside the cell membranes by the concentration gradient without chemical change is called as passive transport [33] . In the passive transport, the substance is transported by the concentration gradient. On the other hand, transporting the substances against the concentration gradient is called as active transport [34] . The active transport is performed by a pump in the cell using the hydrolysis energy of adenosine triphosphate. However, the selective intracellular targeting is difficult to be done using these intracellular transports.
Therefore, we have been focusing on the transport through endocytosis, and the selective cellular uptake can be achieved by designing the surface immobilization states of the nanoparticles. Since several endocytosismediated cellular uptake mechanisms have been proposed, the size of the nanoparticle to be incorporated is also an important factor in cellular uptake. As previously mentioned, the uptake of HA nanoparticles with a size of 50-200 nm (100 μg/mL) has been reported in osteoblasts [35] . In particular, the particle size of about 80 nm for HA particles has been reported to be good for cellular uptake. Specifically, the cells taking up the HA nanoparticles showed the same growth behavior as non-incorporated cells, and the cell affinity with the particles alone was confirmed. It has already been defined that there is toxicity to cells when the cell growth rate is less than 130% in 6 h of culture [36] . As an international standards, the nanoparticle is defined as non-cytotoxicity, if the decrease rate in the cell viability during the cell culture is 30% or less as compared with the case in the cells without the nanoparticle [37] . The HA particles can be judged to be non-cytotoxic in the size range of 50-200 nm [35] according to previous reports [36, 37] . For the cell-labeling, the particle sizes of HA in a media bound to the cells via endocytosis was approximately 120 nm [38] .
Thus, HA is suitable as the matrix for the cell-labeling nanoparticles.
Possibility of Imaging by Photofunctionalization
Hybrids with functional low molecular compounds such as 8hydroxyquinoline (8Hq) [39, 40] [44] . However, the low quantum yield is a problem when compared to existing the cell-labeling nanoparticles.
Thus, detailed understanding of the photophysicochemical driving force at the interface with organic molecules on the HA surface is considered to be important for the design of novel cell-labeling nanoparticles.
Europium (III) ION
Photochemical Properties
For the Ln ions, most of the absorption and luminescence transitions in the infrared to near-ultraviolet region are due to transitions between the split 4f orbital levels [45, 46] . fn electronic configuration is given by the binomial coefficient using the following Equation (1).
where n is the number of 4f electrons. The n of Eu 3+ is 6. The energy diagram of the Eu 3+ ion is shown in Even in strong magnetic fields, the splitting of the energy levels by the Zeeman effect is only a few cm −1 . The J quantum numbers are well defined in the free Eu 3+ ion, but J-mixing occurs when the Eu 3+ is located in a nonspherically symmetric ligand environment [49] . J-mixing is induced by the even-parity components of the crystal-field potential.
The energy levels and wave functions of the Eu 3+ ion can be obtained by diagonalization of the energy matrix [48] . 
where fk and ASO represent the angular part of the electrostatic and spinorbit interaction, respectively. L is the total orbital angular momentum. 
Doping Systems in Hydroxyapatite
There are many ions in vivo that play important roles in the expression of various biological functions. The HA can be given various functions by the substitution of ions in the crystal structure. The studies of ion substitution in the HA crystal structure have been conducted [52] [53] [54] . In particular, it is known that the Ca 2+ can be substituted by various metal ions. Table 2 shows some reports on the doping of Eu 3+ ions into the HA structure which is considered to be useful as a cell-label. Among the Ln ions, the Eu 3+ ion is known to have a low cytotoxicity. The synthesis temperature has been controlled to synthesize the Eu 3+ ion-doped HA.
Excitation and luminescence spectra measurements were performed in the range of the excitation wavelength of 392-394 nm and luminescence wavelength of 612-618 nm [44, [54] [55] [56] . The internal quantum yield, fluorescence lifetime and zeta potential were reported as other evaluation remarks in the references. The fluorescence lifetime of about 0.7-2.0 ms was achieved [44, 55] , the zeta potential of about -10.6 mV was reported [56] , and the internal quantum yield of 2.1% was achieved by the excitation light irradiation of 394 nm [54] . is known to indicate the presence of Eu 3+ ions at the Ca (I) and Ca (II) sites in HA. The 5 D0 to 7 F0 transition peak appears at a maximum fluorescence wavelength of 572 nm at the Ca (I) site and 577 nm at the Ca (II) site [44] .
By separating the peak of these two wavelengths, it is possible to evaluate the ratio of Eu 3+ ions present at the Ca site. The photofunctionalization of HA using the Eu 3+ ion is the subject of study. However, due to the low internal quantum efficiency, almost no study has been reported on its application in the cell labeling. Thus, the state of Eu 3+ ions in the HA is important regarding the luminescence behavior. 
Organic Complex Systems
Types and photochemical properties
As functional low molecular weight compounds, the Eu (III) complexes having a ligand are interesting because of their luminescent properties and have been studied in the biofield and the electronics field. Since the excitation to the T1 includes the inversion of spin, which is a forbidden transition, the probability of the molecule forming the T1 by light absorption is low. The processes of non-radiatively changing from the S1 to T1 or T1 to S1 are called intersystem crossing. When the vibrational levels of the two excited states overlap, the probability of intersystem crossing increases because the change in energy due to the transition is low. Figure 6 shows examples of Eu (III) complexes that have been reported for cell-labeling. Some β-diketonato Eu (III) complexes have been used for the cell-labeling [57, 58] . These reports describe that the Eu (III) complex was dissolved in phosphate buffered saline, then cell-labeling was performed. In the case of the β-diketonato Eu (III) complex of Figure 6a , the excitation/luminescence spectrum was measured at the excitation wavelength of 402 nm and the luminescence wavelength of 614 nm, and the internal quantum yield was 41% [57] . In the case of the βdiketonato Eu (III) complex of Figure 6b , the excitation/luminescence spectrum was measured at the excitation wavelength of 405 nm and the luminescence wavelength of 612 nm, and the internal quantum yield was 23% [58] . However, these available Eu (III) complex luminescent probes have the problem of color degradation, when the probes are exposed to a continuous and intense excitation light for monitoring the biological processes. By introducing an asymmetric coordination field into the Eu (III) complex, the forbidden transition is broken to allow the f-f transition, and the light absorption coefficient can be increased to improve the luminescence intensity. If the symmetry of the ligand can be lowered, application as a cell-labeling probe can be expected. Figure 6 . Eu 3+ complexes of (a, b) β-diketonate ligand [57, 58] . Internal quantum yield of (a) is 41% (λex = 402 nm, λem = 614 nm), and (b) is 23% (λex = 405 nm, λem = 612 nm). The Eu 3+ complexes have been studied for biological labelling applications.
Tris (2,2,6,6-tetramethyl-3,5- 
heptanedionato) europium (III)
The molecular model of tris (2,2,6,6-tetramethyl-3,5-heptanedionato) europium (III) (EuTH) as a complex having the diketonato ligand is shown Regen Med Front. 2020;2(1):e200001. https://doi.org/10.20900/rmf20200001
in Figure 7 . This complex has a highly-symmetrical molecular structure, and is insoluble in water but soluble in ethanol. Due to the high symmetry of the ligand, the luminescence intensity is low.
In the EuTH, it is known that the distance between the Eu-O and the ligand and the coordination structure affect the electron transition [59] .
Different electronic transition states are observed by the coordination symmetry structural change, and the electric dipole transition is strongly observed in the luminescence spectra. Since it can be dissolved in ethanol, the synthesis of a homogeneous hybrid with HA can be expected. 
Possibility of hybrid synthesis of hydroxyapatite with EuTH
Ln complexes incorporated into an inorganic porous matrix, such as zeolite or mesoporous silica, that forms an inorganic-organic hybrid have been reported [60, 61] . The confinement of the Ln complex within the inorganic porous structure not only improves its stability but also reduces the quenching due to aggregation between the Ln complexes. However, the hybrid with luminescent properties based on the inorganic-organic interface of highly biocompatible HA nanoparticles has not been reported.
It is expected that the electron localization between the ligand of the Ln complex and the central metal can be used as a nucleation site of the HA crystals. It was also possible that a high luminescence behavior can be achieved. Specifically, we have been focusing on the electron localization between the central Eu 3+ ion of EuTH and the diketonate ligand. The nucleation of HA in the electron localization of EuTH resulted in the synthesis of the HA-EuTH hybrid [62, 63] . It is suggested that the luminescence intensity can be improved by lowering the symmetry of the EuTH ligand.
SPECIFIC BINDING MOLECULES TO CANCER CELLS
Receptor Expressed on Cell Surface
Receptors are present in all cells. The receptor is a substance and is present on the cell membrane, which specifically binds to a substance outside the cell membrane and is usually a protein. Cells can identify Regen Med Front. 2020;2(1):e200001. https://doi.org/10.20900/rmf20200001 specific substances by receptors and receive information from outside the cells. Binding of the receptor to the substance triggers a variety of responses in the cell. Table 3 shows the types of receptors expressed on the surface of epithelial cancer cells that can be treated with an endoscope [64] [65] [66] [67] [68] [69] .
The types of overexpressed receptors differ depending on the type of cancer. It is known that specific recognition of these receptors enables particle uptake into the cells. Table 3 . Classifications of epithelial cancer cells that can be treated with an endoscope, excess expression receptor on the cells and their binding molecules [64] [65] [66] [67] [68] [69] .
Classification of cancer Excess expression receptor
Classification of binding molecule Reference
Epithelial-derived tumor α-Folate receptor α-Folate [64] Breast cancer Estrogen receptor Estrogen [65] Breast cancer or endometrial cancer Progesterone receptor Progesterone [66] Gastric cancer, breast cancer, ovarian cancer HER2 receptor HER2 [67] Skin cancer Insulin receptor Insulin [68] Metastatic tumor and drug resistant tumor Transferrin receptor Transferrin [69] Types of Molecules that Specifically Bind to Receptors Table 3 also shows the molecules that recognize and specifically bind to the receptors. The recognition of organic molecules or proteins corresponding to the receptor allows the particle uptake into the cells. In order to be used as the cell-labeling nanoparticles, the molecules should be present in the dispersed state on the particle surfaces. The aggregation of the molecules may make it difficult for the receptor to recognize the molecules. Thus, the efficient uptake of HA nanoparticles into the cells becomes possible by immobilizing the cells binding molecules on the HA surface. where, • is a solid surface. Figure 8 shows an example of the immobilization of molecules already reported. Figure 8a shows the immobilization process of APTES on a solid surface. By bonding an amino group-terminated silane coupling agent to the solid surface, the OH group on the solid surface is bonded to Si. Figure   8(b-1,b-2) shows the immobilization processes of molecules on the solid surface. These are examples of the immobilization of a molecule via the APTES [38, 70, 71] . The following is an example of the reaction formula (8) (reaction of Figure 8(b-1) ).
Immobilization Technique of Specific Binding Molecule on Solid
H2N-• +
where, H2N-• is an amino group-immobilized solid surface.
O O O
Regen Med Front. 2020;2(1):e200001. https://doi.org/10.20900/rmf20200001 The surface amino group stably immobilizes the molecule through the peptide (-HN-CO-) bond. Specifically, APTES is bonded to the solid surface by a liquid phase reaction, the solid surface is coated with the -Si-O-Sibond, and the amino group is exposed to the surface. Next, the molecule is formed via a covalent bond to the solid surface by a dehydration condensation reaction (-NH2 + -COOH → -NH-CO-) of an amino group and a carboxylic acid in the molecule. Such a reaction mechanism makes it possible to immobilize folate derivatives (folate N-hydroxysuccinimidyl ester (FA-NHS)), which are known to specifically bind to cancer cells, on the solid surfaces [38] . As the report of the physical surface immobilization technique, the immobilization of ferritin by an electrostatic interaction was achieved on the solid surface [72] . The uptake of the ferritinimmobilized particles into cells was also observed. Thus, for the solid surface, various surface states can be designed.
Regen Med Front. 2020;2(1):e200001. https://doi.org/10.20900/rmf20200001 Table 4 shows examples of cytostatic drug molecules. Vitamin C exerts a strong antioxidant action and generates a large amount of hydrogen peroxide [73] . Although normal cells can neutralize hydrogen peroxide, cancer cells cannot neutralize it, causing cell death. Fucoidan has been shown in basic studies to have the function of transmitting stress signals to the endoplasmic reticulum and inducing cell death [74] . Caffeine has been reported to inhibit cancer cell DNA repair and suppress the growth of cancer cells. It has also been reported that the caspase 9/3 pathway, which is one of the signal transduction pathways causing cell death, functions as a persistent anticancer agent by activation [75] . Citric acid is known to induce cell death by inhibiting the function of proteins involved in cell growth by forming a chelate in the cell with minerals such as iron and calcium [76, 77] . It has also been reported that the glycolytic system of the cell is inhibited to suppress proliferation [78] . If these drug molecules can be hybridized with the HA, they may be applied as the nanoparticles for cancer therapy. Citric Acid Figure 9 shows the molecular structure of citric acid (Figure 9a) , dissociation state in solution (Figure 9b ) and mechanism of suppression of cancer cell growth by citric acid in the cancer cells (Figure 9c) has been reported to suppress the growth of cancer cells and induce cell death. In the blood, iron (III) ions (Fe 3+ ) bind to transferrin and are transported into the cells. Two Fe 3+ ions bind to one transferrin.
CANCER CELL GROWTH INHIBITION DRUGS
Representative Molecules and Their Functions
Transferrin binds to the transferrin receptor located on the cell membrane and is taken up by endocytosis. When it becomes an acidic environment in the lysosome (endosome), Fe 3+ ions are then dissociated into iron (II) ions (Fe 2+ ). It then forms the chelate complex with citric acid, depletes Fe 2+ ions in the cytoplasm, and inhibits the growth of the cells [79] . The dissociation constant pKFe between citric acid and Fe 2+ ion is about 19.7 [80] , and the dissociation constant pKCa between citric acid and Ca 2+ ion is about 4.3 [81] . In the cells, stable chelates are formed between the Fe 2+ ions and citric acid. In normal cells (e.g., prostatic epithelium cells) [82] , it is known that the addition of citric acid has no effect on the cellular activity. The dissociation constant pKFe between citric acid and iron (II) is about 19.7, and the dissociation constant pKCa between citric acid and Ca 2+ is about 4.3. In the cells, stable chelates are formed between Fe 2+ and citrate.
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Hydroxyapatite Nanoparticles Functionalized with Citric Acid
Molecules
Citric acid molecule is used to control the form of HA and is known to exist as the carboxyl ion of -COOin alkaline solution and as a dimer by hydrogen bonding in the form of (-COOH)2 in an acidic solution [83] . Since HA has Ca sites in the a-axis direction and phosphate sites in the c-axis direction, it has been thought that citric acid molecule adsorbs on the Ca sites and affects the formation of the HA nanoparticles. During HA formation in alkaline solution, it has been suggested that the carboxyl ion of the citric acid molecule and Ca 2+ ions of HA chemically bond perpendicular to a-plane (100) on the HA. Citric acid molecule easily forms the chelate with the Ca 2+ ions of the HA. On the basis of these results, it has been considered that the competitive reaction between the HA formation and chelate formation enables the synthesis of hybrid nanoparticles. The synthesis of hybrid nanoparticles can be achieved by utilizing the interaction between ions present at the Ca sites in the HA and carboxyl ions of citric acid molecule.
CONCLUSIONS AND FUTURE PERSPECTIVES
Various types of cell-labeling nanomaterials that stain specific cells have been developed for the non-cytotoxicity visualization. However, two significant problems are known such as color degradation and toxicity in conventional nanomaterials. HA is one of the excellent options to overcome the barriers based on its high biocompatibility; HA is present as a main component of hard tissues in vivo, making it possible to be utilized as a biomaterial. When aiming at the cell-labeling application of HA, it is important to bind a photofunctional molecule with HA in the nucleation process and to synthesize nanoparticles as a form of inorganic-organic hybrid. We have achieved rapid cell-labeling through specific uptake into cancer cells and an easily observable luminescence using the HA-organic complex hybrid. Further studies are now in progress to develop theranostic nanoparticles with fluorescence and therapeutic properties toward future applications in such a field as biomedicine. In order to design novel theranostic nanomaterials, one of the keys would be to control interfacial interactions between HA and organic molecules. To explore the combination of HA and various organic molecules will lead to a large number of multifunctional nanoparticles that advance the frontier technologies of bio-related fields.
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